Abstract

BackgroundStaphylococcus aureus bloodstream infections (BSI) cause significant morbidity and mortality due to the frequent antibiotic resistance, toxin and adhesin production of the bacterium. These characteristics differ significantly in methicillin resistant (MRSA) and methicillin sensitive S. aureus (MSSA) and also among isolates of different MRSA clones, contributing to the outcome of S. aureus bacteraemia.MethodsIn this study, all MRSA BSI isolates from Semmelweis University, Budapest, Hungary, isolated between 2011–2016 and the same number of matched MSSA (overall 306 isolates) were characterised in terms of antibiotic susceptibility, virulence genes, clonality and their association with all-cause 30-day mortality. Effect of patient related variables, such as age, gender and comorbidities were also investigated.ResultsST22-MRSA-IV and ST5-MRSA-II were the most prevalent clones in our study. SCCmec I isolates showed the highest resistance rates and SCCmec II carried most virulence genes. Infections caused by SCCmec IV isolates were associated with the highest mortality rate (42.2%), despite the similar comorbidity rates of the different patient groups. All-cause 30-day mortality was 39.9% in the MRSA and 30.7% in the MSSA group. Increased teicoplanin MIC was associated with high mortality rate. Resistance to ciprofloxacin, erythromycin and clindamycin was common in MRSA, whereas MSSA isolates were more sensitive to all antibiotics with the exception of doxycycline. All MRSA isolates were sensitive to glycopeptides and linezolid; resistance to rifampicin and sulfamethoxazole-trimethoprim was low. MRSA isolates carried more adhesion genes, superantigens were more frequent in MSSA. Panton-Valentine leukocidin was found in 2.3% of the isolates.ConclusionThis study provides insight into the clonal composition and associated mortality of BSI S. aureus isolates in Hungary. The results suggest that the outcome of the infection is determined by the antibiotic resistance, genotype of the bacterium, and patient-related factors; rather than the virulence factors carried by the bacteria.

Highlights

  • Staphylococcus aureus bloodstream infections (BSI) cause significant morbidity and mortality due to the frequent antibiotic resistance, toxin and adhesin production of the bacterium

  • Chronic liver disease and chemotherapy was more frequent in methicillin sensitive S. aureus (MSSA) patients, whereas more of methicillin resistant (MRSA) patients had surgery in the previous 30 days or endocarditis, Charlson comorbidity index did not differ significantly in the two groups (Table 2)

  • Antibiotic resistance of MRSA and MSSA strains Resistance rates of the MRSA isolates were significantly higher towards ciprofloxacin, erythromycin, clindamycin, amikacin, tobramycin and gentamicin compared to MSSA isolates

Read more

Summary

Introduction

Staphylococcus aureus bloodstream infections (BSI) cause significant morbidity and mortality due to the frequent antibiotic resistance, toxin and adhesin production of the bacterium. These characteristics differ signifi‐ cantly in methicillin resistant (MRSA) and methicillin sensitive S. aureus (MSSA) and among isolates of different MRSA clones, contributing to the outcome of S. aureus bacteraemia. Toxin and adhesin production of the bacterium result in significant morbidity and mortality. Antibiotic resistance and virulence of methicillin resistant (MRSA) and methicillin sensitive (MSSA) S. aureus differ significantly, contributing to the variable outcome of S. aureus BSI. Isolates of different MRSA clones vary significantly in their antibiotic susceptibility, virulence and speed of replication, the impact of a specific clone on the clinical outcome of the infection is less studied. Staphylococcal Protein A (SpA) is produced by the vast majority of clinical S. aureus strains and by binds to Fc and Fab domains of IgG antibodies, supresses immune response [4]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call